Chronic Pain

Pain·MeSH: Chronic Pain

Prevalence

8230.9 / 100K

Incidence

3488.0 / 100K/yr

32 drugs in development·19 companies·42 clinical trials

Drug Pipeline by Phase

Approved(11)

Drug	Company
coolief	Avanos Medical Inc. (AVNS)
Cymbalta®	ELI LILLY & Co (LLY)
iovera°	Pacira BioSciences, Inc. (PCRX)
iovera° system	Pacira BioSciences, Inc. (PCRX)
nyloxin	NUTRA PHARMA CORP (NPHC)
oxaydo	Zyla Life Sciences (ZCOR)
pet pain-away	NUTRA PHARMA CORP (NPHC)
Relistor	Bausch Health Companies Inc. (BHC)
Symproic	COLLEGIUM PHARMACEUTICAL, INC (COLL)
venodol	SPOTLIGHT INNOVATION INC. (STLT)
venodol roll-on	SPOTLIGHT INNOVATION INC. (STLT)

Phase 3(4)

Phase 2(4)

Drug	Company
frunevetmab	Nexvet Biopharma plc (NVET)
LY4065967	ELI LILLY & Co (LLY)
nyx-2925	Aptinyx Inc. (APTX)
tilidine / naloxone	AOXING PHARMACEUTICAL COMPANY, INC. (AXN)

Phase 1(4)

Drug	Company
kindolor	GH Research PLC (GHRS)
Lidocaine + Tetracaine	Merus N.V. (MRUS)
prana bio nutrient medicinals p1	UNITED CANNABIS CORP (CNAB)
trv734	TREVENA INC (TRVN)

Preclinical(5)

Unknown(1)

Drug	Company
Cannabis Genomic Study (Sangre AT, LLC)	WEED, INC. (BUDZ)

Early Phase 1(3)

Drug	Company
1200mg Cannabidiol	COLLEGIUM PHARMACEUTICAL, INC (COLL)
400mg Cannabidiol	COLLEGIUM PHARMACEUTICAL, INC (COLL)
800mg Cannabidiol	COLLEGIUM PHARMACEUTICAL, INC (COLL)

BioSniper tracks 32 drugs in development for Chronic Pain across 19 companies.

There are 42 clinical trials targeting Chronic Pain tracked by BioSniper.

The estimated prevalence of Chronic Pain is approximately 8230.9 per 100,000 population.

Full trial data, competitive analysis, and AI-powered pipeline tracking.